Analysis of ongoing pandemic situation, concerns about new variant ba2.86 evading antibodies.
-
Pandemic declared over but still having high cases worldwide. • 0:15
-
Lack of adequate research including histopathology with autopsy analysis. • 0:24
-
Discussion on neutralization escape by sarov 2 Omicron subvariant ba2.86. • 1:00
-
Concerns about new variant evading neutralizing antibodies induced by vaccination or infection. • 3:11
Analysis of global COVID-19 variants and vaccine impact on antibodies.
-
Global transition of COVID-19 variants from April to September 2023. • 4:08
-
EG5.1 variant expanding significantly worldwide. • 4:52
-
Emerging variants commonly sampled in China, Australia, and Sweden. • 5:36
-
Ba286 variant surging in South Africa. • 5:56
-
Impact of Ba286 variant on antibodies studied with bivalent booster. • 6:41
-
Comparison of antibody response with and without bivalent booster. • 7:04
-
Analysis of original variant and Ba286 variant antibody response. • 7:24
Analysis of antibody response to different virus variants and the impact of infection on antibody levels.
-
Antibody response to original virus stronger than variants after booster shot. • 8:03
-
Immune imprinting observed where primary response is still to original virus. • 8:39
-
Significant increase in antibody levels after infection compared to no infection. • 8:58
-
IGG4 levels showed a 38 times increase post third dose of vaccines. • 10:07
-
Different categories of IG breakdown with IG1 and IG3 triggering immune response. • 11:15
Concerns about immune system response, high circulation of virus in vaccinated regions, and rising cases and deaths in Finland.
-
IgG4 triggers tolerance in the immune system • 11:34
-
High IgG4 levels may lead to immune system not responding effectively to infections • 11:50
-
High vaccination levels may contribute to high virus circulation in certain regions • 12:07
-
Importance of understanding immune mechanisms to address mild infections seriously • 12:25
-
Concerns about rising cases and deaths within 30 days in Finland • 13:26
-
Significant increase in cases and deaths as winter approaches • 14:02
-
Need to investigate interaction with IgG4 to understand pandemic phase • 14:57
Uncovering potential causes of mortality beyond severe COVID-19, highlighting concerns about immune response and the need for further investigation.
-
mRNA plays a significant role in the immune response, particularly in the absence of infection or adenovirus vaccines. • 15:07
-
Presence of IgG4 in immune response raises questions about its implications during infection and immune storms. • 15:51
-
Concerns about mild or asymptomatic infections triggering immune storms leading to severe disease and death within three months. • 16:25
-
Emphasizing the importance of understanding immune responses through autopsies for effective mitigation strategies. • 17:03
-
Anticipating a challenging winter in the Northern Hemisphere due to rising numbers and potential impacts of immune responses. • 17:30
-
Highlighting the critical need for answers to address the evolving situation and potential solutions for mitigation. • 17:37